|
May 7
|
Alnylam Issues 2023 Corporate Responsibility Report
|
|
May 5
|
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
|
|
May 3
|
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
|
|
May 3
|
Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Alnylam Pharmaceuticals Inc (ALNY) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
|
|
May 3
|
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
|
|
May 2
|
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
|
|
May 2
|
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
|
|
May 1
|
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
|
|
Apr 30
|
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
|
|
Apr 30
|
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
|
|
Apr 18
|
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
|
|
Apr 8
|
Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick
|
|
Apr 7
|
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
|
|
Mar 29
|
Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63%
|
|
Mar 20
|
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
|
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 13
|
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease
|